These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33586680)

  • 21. Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular vesicle trafficking.
    Kanerva K; Mäkitie LT; Bäck N; Andersson LC
    Exp Cell Res; 2010 Jul; 316(11):1896-906. PubMed ID: 20188728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered brain arginine metabolism in a mouse model of tauopathy.
    Vemula P; Jing Y; Zhang H; Hunt JB; Sandusky-Beltran LA; Lee DC; Liu P
    Amino Acids; 2019 Mar; 51(3):513-528. PubMed ID: 30604097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum.
    Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.
    Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G
    J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
    Hochgräfe K; Sydow A; Mandelkow EM
    FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease.
    Zhang G; Meng L; Wang Z; Peng Q; Chen G; Xiong J; Zhang Z
    Mol Neurodegener; 2022 Jan; 17(1):12. PubMed ID: 35093145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
    PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT
    Perez-Garcia G; Bicak M; Haure-Mirande JV; Perez GM; Otero-Pagan A; Gama Sosa MA; De Gasperi R; Sano M; Barlow C; Gage FH; Readhead B; Ehrlich ME; Gandy S; Elder GA
    Neurosci Lett; 2023 Feb; 797():137080. PubMed ID: 36657633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antizyme Inhibitor 2-Deficient Mice Exhibit Altered Brain Polyamine Levels and Reduced Locomotor Activity.
    Lambertos A; Nuñez-Sanchez MA; López-García C; López-Contreras AJ; Ramos-Molina B; Peñafiel R
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
    Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
    Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antizyme inhibitor 2 hypomorphic mice. New patterns of expression in pancreas and adrenal glands suggest a role in secretory processes.
    López-Garcia C; Ramos-Molina B; Lambertos A; López-Contreras AJ; Cremades A; Peñafiel R
    PLoS One; 2013; 8(7):e69188. PubMed ID: 23874910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy.
    Lyons CE; Graves SI; Razzoli M; Jeganathan K; Mansk RP; McGonigle S; Sabarinathan N; van Deursen JM; Baker DJ; Bartolomucci A
    Psychosom Med; 2024 Jun; 86(5):366-378. PubMed ID: 37910129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antizyme inhibitor 2 (AZIN2) associates with better prognosis of head and neck minor salivary gland adenoid cystic carcinoma.
    Hämetoja H; Andersson LC; Mäkitie A; Bäck L; Hagström J; Haglund C
    APMIS; 2021 Aug; 129(8):503-511. PubMed ID: 34046926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
    J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APP
    Briggs DI; Defensor E; Memar Ardestani P; Yi B; Halpain M; Seabrook G; Shamloo M
    eNeuro; 2017; 4(4):. PubMed ID: 28721361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of ODC Antizyme Inhibitor 2 (AZIN2) in Human Secretory Cells and Tissues.
    Rasila T; Lehtonen A; Kanerva K; Mäkitie LT; Haglund C; Andersson LC
    PLoS One; 2016; 11(3):e0151175. PubMed ID: 26963840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue.
    Kaufman SK; Thomas TL; Del Tredici K; Braak H; Diamond MI
    Acta Neuropathol Commun; 2017 Jun; 5(1):41. PubMed ID: 28587664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
    Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.